Danysz A, Oledzka K, Bukowska-Kiliszek M. Influence of coenzyme Q-10 on the
hypotensive effects of enalapril and nitrendipine in spontaneously hypertensive
rats. Pol J Pharmacol. 1994;46(5):457-461.
Iarussi D, Auricchio U, Agretto A, Murano A, Giuliano M, Casale F, et al.
Protective effect of coenzyme Q on anthracylines cardiotoxicity: Control study
in children with acute lymphoblastic leukemia and non-hodgkin lymphoma. Molec
Aspects Med. 1994;15(Suppl):S207-S212.
Landbo C, Almdal TP. [Interaction between warfarin and coenzyme Q10 (see
comments)]. Ugeskr Laeger. 1998;160(22):3225-3227.
Portakal O, Inal-Erden M. Effects of pentoxifylline and coenzyme Q10 in
hepatic ischemia/reperfusion injury. Clin Biochem. 1999;32:461-466.
Shinozawa S, Kawasaki H, Gomita Y. [Effect of biological membrane stabilizing
drugs (coenzyme Q10, dextran sulfate and reduced glutathione) on adriamycin
(doxorubicin)-induced toxicity and microsomal lipid peroxidation in mice].
Gan To Kagaku Ryoho. 1996;23(1):93-98.
Singh RB, Niaz MA, Rastogi SS, Shukla PK, Thakur AS. Effect of hydrosoluble
coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients
with coronary artery disease. J Hum Hypertens. 1999;13(3):203-208.
Spigset O. Reduced effect of warfarin caused by ubidecarenone. The
Lancet. 1994;344:1372-1373.
Takahashi N, Iwasaka T, Sugiura T, et al. Effect of coenzyme Q10 on
hemodynamic response to ocular timolol. J Cardiovasc Pharmacol.
1989;14:462-468.
Zhou Q, Chan E. Accuracy of repeated blood sampling in rats: A new technique
applied in pharmacokinetic/pharmacodynamic studies of the interaction between
warfarin and Co-enzyme Q10.
J Pharmacol Toxicol Methods.
1998;40(4):191-199.